Author:
Sonnenberg Elena,Schaafs Patricia
Publisher
Springer Berlin Heidelberg
Reference23 articles.
1. Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS (2013) Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 19(1):15–22
2. Broms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H (2014) Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis 20(6):1091–1098
3. Hutson JR, Matlow JN, Moretti ME, Koren G (2013) The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol 33(1):1–8
4. Hviid A, Molgaard-Nielsen D (2011) Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 183(7):796–804
5. Kane SV, Acquah LA (2009) Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 104(1):228–233